β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart Failure

Completed

• Conditions: Acute Myocardial Infarction

• Registration Number: NCT02786654
• Lead Sponsor: University of Leeds

Brief Summary

The aim of the study is to investigate the association between the use of β blockers and mortality among hospital survivors of acute myocardial infarction without heart failure.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-01
• Primary Completion: 2013-06
• Study Completion: 2013-06
• Study First Submitted: 2016-05-26
• Study First Submitted QC: 2016-05-26
• Study First Posted: 2016-06-01
• Status Verified: 2019-06
• Last Update Submitted: 2019-06-14
• Last Update Posted: 2019-06-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 179810

Inclusion Criteria

• acute myocardial infarction patients only
• aged 18 to 100 years

Exclusion Criteria

• other final diagnosis besides acute myocardial infarction
• died in-hospital
• patients with missing mortality data
• aged > 100
• patients with previous acute myocardial infarction or angina
• patients who have received coronary interventions before
• patients with heart failure
• patients with β blocker prior use
• patients contraindicated for β blocker use
• patients with use of a loop diuretic

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
All cause mortality	1 year

Secondary Outcome Measures

Name	Time	Method
All cause mortality	30 days

Trial Locations

Locations (1)

University of Leeds; 🇬🇧 Leeds, United Kingdom